Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Nasdaq Real Time Price USD

STERIS plc (STE)

Compare
212.61
-8.80
(-3.97%)
At close: April 4 at 4:00:02 PM EDT
212.61
0.00
(0.00%)
After hours: April 4 at 5:50:47 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Daniel A. Carestio President, CEO & Director 2.17M -- 1973
Mr. Michael J. Tokich Senior VP & CFO 1.03M -- 1969
Mr. John Adam Zangerle Senior VP, General Counsel & Secretary 899.11k -- 1967
Ms. Mary Clare Fraser SVP & Chief Human Resources Officer 692k -- 1971
Mr. Cary L. Majors Senior VP & President of Healthcare 796.95k -- 1975
Ms. Karen L. Burton VP & Chief Accounting Officer -- -- 1968
Ms. Julie Winter Vice President of Investor Relations & Corporate Communications -- -- --
Ms. Julia K. Madsen Senior VP & GM of Life Sciences -- -- 1965
Mr. Andrew Xilas Senior VP & GM of Dental 1.44M -- 1965
Mr. Kenneth E. Kohler Senior VP & GM of AST -- -- 1963

STERIS plc

5960 Heisley Road
Mentor, OH 44060
United States
440 354 2600 https://www.steris.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
18,000

Description

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Corporate Governance

STERIS plc’s ISS Governance QualityScore as of April 1, 2025 is 6. The pillar scores are Audit: 8; Board: 3; Shareholder Rights: 8; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 6, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC

STERIS plc Earnings Date

Recent Events

March 21, 2025 at 12:00 AM UTC

Dividend Date

March 3, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 20, 2025 at 12:00 AM UTC

Ex-Dividend Date

February 7, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

February 5, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 8, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

November 7, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

November 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 21, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

October 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers